Your browser doesn't support javascript.
loading
Hepatic Arterial Infusion Chemotherapy Plus Lenvatinib and Tislelizumab with or Without Transhepatic Arterial Embolization for Unresectable Hepatocellular Carcinoma with Portal Vein Tumor Thrombus and High Tumor Burden: A Multicenter Retrospective Study.
Chen, Song; Shi, Feng; Wu, Zhiqiang; Wang, Liguang; Cai, Hongjie; Ma, Ping; Zhou, Yuanmin; Mai, Qicong; Wang, Fan; Tang, Shuangyan; Zhuang, Wenquan; Lai, Jiaming; Chen, Xiaoming; Chen, Huanwei; Guo, Wenbo.
Afiliación
  • Chen S; Department of Minimally Invasive Interventional Therapy, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, People's Republic of China.
  • Shi F; Department of Interventional Radiology, Guangdong Provincial People's Hospital, Guangzhou, People's Republic of China.
  • Wu Z; Department of Interventional Radiology, the First Affiliated Hospital of Sun Yat-sen University, Guangzhou, People's Republic of China.
  • Wang L; Department of Hepatopancreatic Surgery, the First People's Hospital of Foshan, Foshan, People's Republic of China.
  • Cai H; Department of Interventional Radiology, the First Affiliated Hospital of Sun Yat-sen University, Guangzhou, People's Republic of China.
  • Ma P; Department of Oncology, the Twelfth People's Hospital of Guangzhou, Guangzhou, People's Republic of China.
  • Zhou Y; Department of Oncology, the Twelfth People's Hospital of Guangzhou, Guangzhou, People's Republic of China.
  • Mai Q; Department of Interventional Radiology, Guangdong Provincial People's Hospital, Guangzhou, People's Republic of China.
  • Wang F; Department of Interventional Radiology, the First Affiliated Hospital of Sun Yat-sen University, Guangzhou, People's Republic of China.
  • Tang S; Department of Interventional Radiology, the First Affiliated Hospital of Sun Yat-sen University, Guangzhou, People's Republic of China.
  • Zhuang W; Department of Interventional Radiology, the First Affiliated Hospital of Sun Yat-sen University, Guangzhou, People's Republic of China.
  • Lai J; Center of Hepato-Pancreato-Biliary Surgery, the First Affiliated Hospital of Sun Yat-sen University, Guangzhou, People's Republic of China.
  • Chen X; Department of Interventional Radiology, Guangdong Provincial People's Hospital, Guangzhou, People's Republic of China.
  • Chen H; Department of Hepatopancreatic Surgery, the First People's Hospital of Foshan, Foshan, People's Republic of China.
  • Guo W; Department of Interventional Radiology, the First Affiliated Hospital of Sun Yat-sen University, Guangzhou, People's Republic of China.
J Hepatocell Carcinoma ; 10: 1209-1222, 2023.
Article en En | MEDLINE | ID: mdl-37533600

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Clinical_trials / Observational_studies / Risk_factors_studies Idioma: En Revista: J Hepatocell Carcinoma Año: 2023 Tipo del documento: Article Pais de publicación: Nueva Zelanda

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Clinical_trials / Observational_studies / Risk_factors_studies Idioma: En Revista: J Hepatocell Carcinoma Año: 2023 Tipo del documento: Article Pais de publicación: Nueva Zelanda